Schwartz Aharon 4
4 · Protalix BioTherapeutics, Inc. · Filed Aug 12, 2025
Insider Transaction Report
Form 4
Schwartz Aharon
Director
Transactions
- Purchase
Common Stock
2025-06-10$1.60/sh+129,000$205,884→ 303,000 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.60 to $1.575 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.